Low vs standard dose valganciclovir
Acute rejection · solid organ transplant recipients
Low showed no clear difference in acute rejection compared with standard dose valganciclovir (low certainty).
1 finding from 1 review
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 2024 · Cochrane Headline outcomes onlyRR 0.33 [0.07, 1.61]1 study · 196 participantsLow